Behind the Science: A New Path to Tackling Metastatic Breast Cancer
At Pfizer, our scientists are committed to advancing innovation that could one day improve outcomes for patients living with certain forms of metastatic breast cancer (MBC), which impacts approximately 170,000 women in the US.
